This content is in French.
IL6 receptor inhibitors: exploring the therapeutic potential of several diseases using Mendelian randomisation of drug targets
11 septembre 2024
Elevated levels of interleukin-6 are correlated with diseases such as cancer, autoimmune diseases and infections. IL-6 receptor inhibitors (IL-6Ri), used for rheumatoid arthritis and COVID-19, may have wider uses.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
